| Lung Cancer Cases | Controls | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Characteristic | Total | GRPR Positive | GRPR Negative | P | Total | GRPR Positive | GRPR Negative | P | ||||
N | 224 | 158 | 70.5% | 66 | 29.5% | Â | 107 | 41 | 38.3% | 66 | 61.7% | Â |
Age | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
   Median (Range) | 224 | 67 (42-84) | 70 (41-85) | 0.01*†|  | 52 (31-80) | 52 (31-83) | 0.44†| ||||
Sex | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
   Male | 105 | 75 | 71.4% | 30 | 28.6% | 0.78‡ | 60 | 20 | 33.3% | 40 | 66.7% | 0.23‡ |
   Female | 119 | 83 | 69.7% | 36 | 30.3% |  | 47 | 21 | 44.7% | 26 | 55.3% |  |
Ethnicity | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
   Caucasian | 213 | 150 | 70.4% | 63 | 29.6% | 1.00§ | 101 | 38 | 37.6% | 63 | 62.4% | 0.67§ |
   Non-Caucasian | 10 | 7 | 70.0% | 3 | 30.0% |  | 6 | 3 | 50.0% | 3 | 50.0% |  |
Smoking Status | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
   Never Smoker | 19 | 17 | 89.5% | 2 | 10.5% | 0.03*§ | 33 | 11 | 33.3% | 22 | 66.7% | 0.02*§ |
   Former Smoker | 111 | 70 | 63.1% | 41 | 36.9% |  | 57 | 18 | 31.6% | 39 | 68.4% |  |
   Active Smoker | 87 | 65 | 74.7% | 22 | 25.3% |  | 14 | 10 | 71.4% | 4 | 28.6% |  |
Pulmonary Function | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
   Normal | 89 | 62 | 69.7% | 27 | 30.3% | 0.52§ | 36 | 18 | 50.0% | 18 | 50.0% | 0.22§ |
   Mild Obstruction | 14 | 9 | 64.3% | 5 | 35.7% |  | 5 | 2 | 40.0% | 3 | 60.0% |  |
   Moderate Obstruction | 52 | 37 | 71.2% | 15 | 28.8% |  | 16 | 5 | 31.3% | 11 | 68.8% |  |
   Severe Obstruction | 37 | 30 | 81.1% | 7 | 18.9% |  | 46 | 13 | 28.3% | 33 | 71.7% |  |
Pack-Years | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
   Median (Range) | 222 | 50 (0-150) | 50 (0-120) | 0.94†|  | 40 (0-110) | 25 (0-156) | 0.11†| ||||
Disease Stage | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
   CIS | 1 | 1 | 100.0% | 0 | 0.0% | 0.49§ | - | - |  | - |  | - |
   1 | 98 | 69 | 70.4% | 29 | 29.6% |  | - | - |  | - |  |  |
   2 | 38 | 24 | 63.2% | 14 | 36.8% |  | - | - |  | - |  |  |
   3 | 49 | 39 | 79.6% | 10 | 20.4% |  | - | - |  | - |  |  |
   4 | 16 | 11 | 68.8% | 5 | 31.3% |  | - | - |  | - |  |  |
Histology | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
   Adenocarcinoma | 112 | 74 | 66.1% | 38 | 33.9% | 0.50§ | - | - |  | - |  | - |
   Squamous cell carcinoma | 60 | 47 | 78.3% | 13 | 21.7% |  | - | - |  | - |  |  |
   Other NSCLC | 27 | 19 | 70.4% | 8 | 29.6% |  | - | - |  | - |  |  |
   Small cell lung cancer | 10 | 8 | 80.0% | 2 | 20.0% |  | - | - |  | - |  |  |
   Other/unknown | 15 | 10 | 66.7% | 5 | 33.3% |  | - | - |  | - |  |  |